WHO warns against relying solely on weight loss drugs for obesity treatment

The World Health Organization (WHO) is conducting its first review of obesity management guidelines in over 20 years, starting with guidelines for treating children and adolescents with obesity. The WHO's nutrition chief, Francesco Branca, has cautioned that new weight loss drugs like Novo Nordisk's Wegovy are not a "silver bullet" for addressing the global obesity epidemic and must be part of a comprehensive approach that includes diet and exercise. The WHO's revised guidelines will be based on more robust methodology and up-to-date science, with the first draft expected by the end of this year.